James Christensen
Director/Board Member presso BOUNDLESS BIO, INC.
Patrimonio netto: - $ in data 31/03/2024
Profilo
Attualmente James G. Christensen ricopre la posizione di direttore scientifico e vicepresidente esecutivo di Mirati Therapeutics, Inc. È anche nel consiglio di amministrazione della BCTG Acquisition Corp. In passato è stato Senior Director-Oncology Precision Medicine alla Pfizer Inc. Il dott. Christensen ha ricevuto un dottorato dalla North Carolina State University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
BOUNDLESS BIO INC.
-.--% | 28/03/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Posizioni attive di James Christensen
| Società | Posizione | Inizio |
|---|---|---|
| BOUNDLESS BIO, INC. | Director/Board Member | 02/10/2023 |
Precedenti posizioni note di James Christensen
| Società | Posizione | Fine |
|---|---|---|
| MIRATI THERAPEUTICS | Chief Tech/Sci/R&D Officer | 23/01/2024 |
| PFIZER, INC. | Corporate Officer/Principal | 01/01/2013 |
| TANGO THERAPEUTICS, INC. | Director/Board Member | - |
Formazione di James Christensen
| North Carolina State University | Doctorate Degree |
| Northern Illinois University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| PFIZER, INC. | Health Technology |
| BOUNDLESS BIO, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Mirati Therapeutics, Inc.
 Mirati Therapeutics, Inc. BiotechnologyHealth Technology Mirati Therapeutics, Inc. operates as a clinical-stage oncology company. engages in the development of novel therapeutics. The firm's products target the genetic and immunological promoters of cancer. Its clinical pipeline consists of Adagrasib, MRTX1133, and Sitravatinib. The company was founded on December 13, 1995, and is headquartered in San Diego, CA. | Health Technology |
BCTG Acquisition Corp.
 BCTG Acquisition Corp. Financial ConglomeratesFinance BCTG Acquisition Corp. operates as a blank check company. It is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded in May 2020 and is headquartered in San Diego, CA. | Finance |
- Borsa valori
- Insiders
- James Christensen
